3 Things Gilead' CEO Just Said That You'll Want to Know

When John Milligan speaks, people listen -- especially if they're Gilead Sciences (NASDAQ:GILD) shareholders.

The big biotech's CEO and its CFO Robin Washington sat down to field questions at the RBC Capital Markets 2017 Healthcare Conference in New York City on Wednesday. Milligan spoke directly to some of the most pressing concerns for Gilead shareholders. Here are three things he said that you'll definitely want to know.

Back to news